8-K: Silo Pharma, Inc. — Item 1.01 Entry into a Material Definitive Agreement
Filed: 2026-10-02 AccNo: 0001213900-26-106435 Size: 353 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Se
Filed: 2026-10-02 AccNo: 0001213900-26-106435 Size: 353 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Se